COVID-19-Related Death in Patients with Alcohol or Substance Use Disorders.

IF 2.8 3区医学 Q2 PSYCHIATRY

European Addiction Research Pub Date : 2023-01-01 DOI:10.1159/000527542

Raimondo Maria Pavarin, Dario Consonni, Fabio Lucchi, Paolo Pandolfi, Silvia Marani, Francesco Palmese, Marco Domenicali

{"title":"COVID-19-Related Death in Patients with Alcohol or Substance Use Disorders.","authors":"Raimondo Maria Pavarin, Dario Consonni, Fabio Lucchi, Paolo Pandolfi, Silvia Marani, Francesco Palmese, Marco Domenicali","doi":"10.1159/000527542","DOIUrl":null,"url":null,"abstract":"Background: People with substance or alcohol use disorders (SUDs/AUDs) are likely to be more vulnerable to COVID-19 infection than the general population, but the evidence of COVID-19-related mortality in these patients is unclear.Objectives: The aim of the study was to verify whether patients with AUD and SUD have a higher mortality rate for COVID-19-related mortality compared to the general population.Method: We performed a follow-up study to assess mortality in 2020 in a cohort of patients diagnosed for the first time with AUDs or SUDs at the Public Health Services in the metropolitan area of Bologna (Northern Italy) from 2009 to 2019.Results: SUDs/AUDs patients present an excess mortality with respect to the general population for all causes of death and for COVID-19-related mortality.Conclusions: Our data support the need for prevention strategies in SUDs/AUDs patients such as vaccinations.","PeriodicalId":11902,"journal":{"name":"European Addiction Research","volume":"29 1","pages":"67-70"},"PeriodicalIF":2.8000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892992/pdf/ear-0029-0067.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Addiction Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000527542","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 1

Abstract

Background: People with substance or alcohol use disorders (SUDs/AUDs) are likely to be more vulnerable to COVID-19 infection than the general population, but the evidence of COVID-19-related mortality in these patients is unclear.

Objectives: The aim of the study was to verify whether patients with AUD and SUD have a higher mortality rate for COVID-19-related mortality compared to the general population.

Method: We performed a follow-up study to assess mortality in 2020 in a cohort of patients diagnosed for the first time with AUDs or SUDs at the Public Health Services in the metropolitan area of Bologna (Northern Italy) from 2009 to 2019.

Results: SUDs/AUDs patients present an excess mortality with respect to the general population for all causes of death and for COVID-19-related mortality.

Conclusions: Our data support the need for prevention strategies in SUDs/AUDs patients such as vaccinations.

查看原文本刊更多论文

酒精或物质使用障碍患者与covid -19相关的死亡

背景:物质或酒精使用障碍患者(sud /AUDs)可能比一般人群更容易感染COVID-19，但这些患者中与COVID-19相关的死亡率证据尚不清楚。目的:本研究的目的是验证AUD和SUD患者的covid -19相关死亡率是否高于普通人群。方法:我们进行了一项随访研究，以评估2009年至2019年在意大利北部博洛尼亚大都市区公共卫生服务部门首次诊断为aud或sud的患者在2020年的死亡率。结果:就所有死因和covid -19相关死亡率而言，sud /AUDs患者的死亡率高于一般人群。结论:我们的数据支持在sud /AUDs患者中需要预防策略，如接种疫苗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Addiction Research SUBSTANCE ABUSE-PSYCHIATRY

CiteScore

6.80

自引率

5.10%

发文量

审稿时长

>12 weeks

期刊介绍： ''European Addiction Research'' is a unique international scientific journal for the rapid publication of innovative research covering all aspects of addiction and related disorders. Representing an interdisciplinary forum for the exchange of recent data and expert opinion, it reflects the importance of a comprehensive approach to resolve the problems of substance abuse and addiction in Europe. Coverage ranges from clinical and research advances in the fields of psychiatry, biology, pharmacology and epidemiology to social, and legal implications of policy decisions. The goal is to facilitate open discussion among those interested in the scientific and clinical aspects of prevention, diagnosis and therapy as well as dealing with legal issues. An excellent range of original papers makes ‘European Addiction Research’ the forum of choice for all.